Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
gasseri inhibited RSL3-induced ferroptosis in NCM-460 cells, with the mechanism involving activation of the GSH/GPX4 signaling pathway
Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026
Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury
FANCL is also known for its synergistic formulation of supplements using natural ingredients and key coenzyme combinations
US$ 23.25
US$ 28.13
US$ 26.95
US$ 29.43
